ABRT.CNCNQHealthcare · Biotechnology

Albert Labs International Corp.

$0.01+0.00%(+$0.00)

TickerSpark Score

49/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABRT.CN research report →

52-Week Range0% of range

Low $0.01

Current $0.01

High $0.04

Companyalbertlabs.com

Albert Labs International Corp. operates as a clinical research and drug development company. The company focuses on treating patients with urgent and unmet needs, including critical mental health indications.

CEO: Navchand Jagpal
IPO: 2023
HQ: Burnaby, BC, CA

Price Chart

-87.50% · this period

Valuation

Market Cap: $372.07K
P/E: -0.04
P/S: 0.00
P/B: -0.77
EV/EBITDA: -0.07
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 1626.75%
ROIC: 1132.70%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-7,058,813 · -275.68%
EPS: $-0.13 · 72.34%
Op Income: $-4,137,951
FCF YoY: -42.02%

Performance & Tape

52W High: $0.04
52W Low: $0.01
50D MA: $0.01
200D MA: $0.01
Beta: 2.14
Avg Volume: 0

Get TickerSpark's AI analysis on ABRT.CN

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime